Risedronate for Men With Osteoporosis
On August 11, 2006, the FDA approved generic risedronate sodium tablets (Actonel, Procter & Gamble) 35 mg to increase bone mass in men with osteoporosis. Actonel 5 mg was approved in 2000 for use in men and women to prevent and treat steroid-induced osteoporosis. Actonel 35 mg is also approved to prevent and treat osteoporosis [...]
Read User's Comments





